Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wenwei A Yaranji Tablets for abnormal mucus-type epigastric distension and pain with reduced appetite
CTR20231078Phase 3Active
- Sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
- Start
- May 2023
- Countries
- 1
01
Overview
A Phase 3 trial of Wenwei Ayaranji Tablets in functional dyspepsia (FD), sponsored by Xinjiang Uygur Pharmaceutical Co., Ltd.. Started May 2023; status: active.
02
Drugs
Wenwei Ayaranji Tablets
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on CTR20231078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231078.